Trientine is a copper-chelating agent used as second-line therapy for Wilson's disease, prescribed when patients cannot tolerate penicillamine.
- Indication: Wilson's disease (hepatolenticular degeneration)
- Mechanism: Binds excess copper for safe urinary excretion, preventing hepatic and neurological damage
- Treatment duration: Lifelong, continuous therapy — not a short course
- Patient profile: Genetically diagnosed Wilson's disease patients, typically identified in adolescence to early adulthood
- Why it matters for buyers: Recurring, predictable demand pattern — relevant for distributors and NGOs planning long-term supply contracts rather than one-time bulk orders
- Legal status: Schedule H — dispensed only against valid prescription
- Administration: Capsules must be swallowed whole; do not crush or chew
- Serious but rare risks: Hypersensitivity reactions, anemia
- Dietary interaction: Copper-rich foods (shellfish, nuts, organ meats, chocolate) should be limited during treatment
- Pregnancy: Continued only under direct specialist supervision, risk-benefit assessed case by case
- Manufacturing site: Own USFDA-approved facility, Gujarat, India
- Certifications: WHO-GMP, EU-GMP, ISO 9001 quality systems
- Supply model: Direct manufacturer — not a trading intermediary
- Advantage for buyers: Single point of quality accountability, consistent batch-to-batch specifications, no multi-vendor delay risk
| Document |
Included |
| WHO-GMP / EU-GMP Certificate |
? Standard |
| Certificate of Pharmaceutical Product (COPP) |
? Standard |
| Certificate of Analysis (batch-specific) |
? Standard |
| Free Sale Certificate |
? Standard |
| MSDS |
? Standard |
| Patient Information Leaflet |
? Standard |
| CTD/ACTD Dossier |
On request (for market registration) |
Stock status: Available now | MOQ: Flexible — scaled for distributors, hospitals, and NGOs of all sizes
- Export reach: 200+ countries
- Logistics: WHO-GDP compliant, temperature-controlled (air and sea freight)
- Established markets: LATAM, GCC/Middle East, Africa
- Emerging demand: Southeast Asia (Cambodia, Vietnam, Philippines, Myanmar)
- Why buyers choose India sourcing here: Competitive pricing + manufacturer-side registration support in one supplier
- India supply: PAN-India hospital and pharmacy availability
- Unregistered markets: Named-patient / compassionate-use import pathway supported
- NGO/procurement partnerships: Direct engagement for rare-disease access programs
- First-time importers: Import licensing guidance provided
What is Trientine used for?
Treats Wilson's disease by binding excess copper so the body can safely eliminate it.
Get Trientine price from a GMP-compliant Indian manufacturer — how?
Send required quantity and destination country for a verified quote within 24 hours.
Is Trientine available if not registered in my country?
Yes, via named-patient / compassionate-use import — the standard pathway in most countries.
Can NGOs source Trientine for access programs?
Yes, including support with first-time import licensing.
Is registration documentation provided?
Yes — CTD/ACTD dossiers, COPP, and full batch documentation available.
Are MOQs flexible for smaller distributors?
Yes, scaled for buyers of all sizes.
